HOOKIPA Pharma: two directors resign; Julie O'Neill appointed Non-Executive Chair

HOOKIPA Pharma Inc.

Jan van de Winkel and Tim Reilly resign effective Aug 30, 2024, citing increased time commitments from other roles.
Julie O'Neill appointed Non-Executive Chair; Board reduced from 6 to 5 members.
Board reclassified into three classes; O'Neill reappointed as Class I director, term expiring at 2026 Annual Meeting.
Audit Committee: Cassidy (Chair), Kaufman, O'Neill; Compensation: O'Neill (Chair), Cassidy; Nominating: Kaufman (Chair), Cassidy.
Resignations not due to any disagreement with Company's operations, policies, or practices.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Julie O'Neill

non-executive chair

HOOK · HOOKIPA Pharma Inc.

Effective: 2024-08-30
Filed: August 30, 2024, 7:59 PM ET

the Company’s board of directors (the “Board”) appointed Julie O’Neill to serve as non-executive chair of the Board, effective as of the Effective Time.

Departed

Jan van de Winkel

director

HOOK · HOOKIPA Pharma Inc.

Effective: 2024-08-30
Filed: August 30, 2024, 7:59 PM ET

On August 27, 2024, Jan van de Winkel, Ph.D., notified HOOKIPA Pharma Inc. (the “Company”) of his resignation as a director of the Company, effective as of August 30, 2024 at 12:00 p.m. Eastern Time

Departed

Timothy Reilly

director

HOOK · HOOKIPA Pharma Inc.

Effective: 2024-08-30
Filed: August 30, 2024, 7:59 PM ET

On August 27, 2024, Timothy Reilly, Ph.D., notified the Company of his resignation as a director of the Company, effective as of the Effective Time.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Julie O'Neill was appointed as non-executive chair at HOOKIPA Pharma Inc..

Action: appointed
Role: non-executive chair

Exact text from the filing

the Company’s board of directors (the “Board”) appointed Julie O’Neill to serve as non-executive chair of the Board, effective as of the Effective Time.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Jan van de Winkel resigned as director at HOOKIPA Pharma Inc..

Action: resigned
Role: director

Exact text from the filing

On August 27, 2024, Jan van de Winkel, Ph.D., notified HOOKIPA Pharma Inc. (the “Company”) of his resignation as a director of the Company, effective as of August 30, 2024 at 12:00 p.m. Eastern Time

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Timothy Reilly resigned as director at HOOKIPA Pharma Inc..

Action: resigned
Role: director

Exact text from the filing

On August 27, 2024, Timothy Reilly, Ph.D., notified the Company of his resignation as a director of the Company, effective as of the Effective Time.

View on SEC.gov

HOOKIPA Pharma Inc. filing history →

Source: SEC EDGAR

accession 0001104659-24-095236

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.